Roche's Chugai strikes $200M M&A deal to take over IgAN asset in several Asian countries

24th October 2025 Uncategorised 0

Last year, Japan’s Renalys picked up certain Asian rights to the IgAN medicine sparsentan from the medicine’s developer, Travere Therapeutics. Chugai is set to take the medicine forward in the licensed countries under a new M&A deal.

More: Roche's Chugai strikes 0M M&A deal to take over IgAN asset in several Asian countries
Source: fierce